ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

The polymerase chain reaction refers to the technique that yields numerous copies of a precise gene(s) that are isolated from the DNA in vitro. This chain reaction depends on a thermostable DNA polymerase, which is also known as TAQ polymerase. This is extracted from the thermophilic bacteria, which reside in hot springs and hydrothermal vents. The PCR involves repeat cycles through a series of tightly regulated temperature that helps to yield millions of copies of the target region from the DNA. In revenue terms, the market polymerase chain reaction in the Asia Pacific region had created $XX million in 2018 and is likely to account for $XX million in 2027, while evolving at a 6.73% of CAGR. The base year regarded for the study of the market is 2018, whereas the expected period is from 2019 to 2027.

ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

Asia-pacific Polymerase Chain Reaction Market by Technology (Real-time Pcr, Traditional Pcr, Digital Pcr) by Product (Reagent and Consumables, Instruments, Software, Services) by Application (Clinical, Research, Forensics) by End-user (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Academic and Research Institutes) by Geography.

Request free sample

The polymerase chain reaction refers to the technique that yields numerous copies of a precise gene(s) that are isolated from the DNA in vitro. This chain reaction depends on a thermostable DNA polymerase, which is also known as TAQ polymerase. This is extracted from the thermophilic bacteria, which reside in hot springs and hydrothermal vents. The PCR involves repeat cycles through a series of tightly regulated temperature that helps to yield millions of copies of the target region from the DNA.

In revenue terms, the market polymerase chain reaction in the Asia Pacific region had created $XX million in 2018 and is likely to account for $XX million in 2027, while evolving at a 6.73% of CAGR. The base year regarded for the study of the market is 2018, whereas the expected period is from 2019 to 2027.

Japan, China, South Korea, India, Australia, and the Rest of Asia Pacific are the countries that are taken into consideration for the market study. The prominent factors influencing the market growth in this region are, namely, the ever-increasing elderly population and rising cases of chronic diseases. However, growing non-validated home-brew tests and compensation issues are the factors that are limiting the growth of the market. Also, precision and appropriate results for RT-PCR would further challenge the PCR market. The advent of easy to use PCR devices will open avenues for the PCR market.

The demand for ground-breaking technologies for early and accurate diagnosis of infectious and chronic diseases, expiry of key players PCR patents paired with increasing demand for genetic and molecular testing and advent of digital PCR are some of the major key factors which are promoting the growth of the market owing to the vast populations with a growing risk of diseases which is boosting the growth of the region.

Thermo Fisher Scientific Inc., Agilent Technologies Inc., Tahara Bio Inc., Qiagen N.V., Pacific Biosciences of California, Inc., F. Hoffman La Roche Ltd., Biomerieux SA, Abbott Laboratories, MDXhealth Corporation, Danaher Corporation, Fluidigm Corporation, Becton Dickinson Biosciences Systems and Reagents Inc., Siemens Healthineers, and Nano Biosys Inc. are the players that are discussed in this report.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REAGENTS AND CONSUMABLES HOLDS THE LARGEST MARKET SHARE
      • RISE IN INFECTIOUS DISEASES WORLDWIDE
      • INCREASING DEMAND FOR DIGITAL PCR
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • RISING INCIDENCES OF INFECTIONS AND DISEASES
      • DEVELOPMENT IN PHARMACOGENOMICS
      • EMERGENCE OF DIGITAL PCR
      • INCREASING PUBLIC-PRIVATE INVESTMENTS AND GRANTS
    • MARKET RESTRAINTS
      • NON-VALIDATED HOME BREW TESTS
      • HIGH DEVICE COSTS ASSOCIATED WITH PCR
      • NECESSITY OF TRAINING AND UPDATATION OF LABORATORIES WORKERS
    • MARKET OPPORTUNITIES
      • RISE IN FUNDING OF GENE AND HUMAN GENOME PROJECTS
      • EXPANDING HEALTHCARE MARKET IN APAC
    • MARKET CHALLENGES
      • INACCURACY CAUSED BY THE PCR TECHNIQUES
      • INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
  1. MARKET BY TECHNOLOGY
    • REAL-TIME PCR
    • TRADITIONAL PCR
    • DIGITAL PCR
  2. MARKET BY PRODUCT
    • REAGENT AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE
    • SERVICES
  3. MARKET BY APPLICATION
    • CLINICAL
    • RESEARCH
    • FORENSICS
  4. MARKET BY END USER
    • DIAGNOSTIC CENTERS & HOSPITALS
    • BIOTECH & PHARMA COMPANIES
    • ACADEMIC AND RESEARCH INSTITUTES
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  6. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
  1. COMPANY PROFILES
    • AGILENT TECHNOLOGIES INC.
    • BIORAD TECHNOLOGIES INC.
    • QIAGEN N.V.
    • HOFFMAN LA ROCHE LTD.
    • THERMOFISHER SCIENTIFIC INC.
    • ABBOTT LABORATORIES
    • BECTON DICKINSON BIOSCIENCES SYSTEMS AND REAGENTS INC.
    • SIEMENS HEALTHINEERS
    • BIOMERIEUX SA
    • DANAHER CORPORATION
    • MDXHEALTH CORPORATION
    • NANO BIOSYS INC.
    • TAHARA BIO INC.
    • FLUIDIGM CORPORATION
    • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

 

TABLE LIST

TABLE 1. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 2. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 3. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 4. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2019-2027 (IN $ MILLION)

TABLE 5. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2019-2027 (IN $ MILLION)

TABLE 6. OPPORTUNITY MATRIX

TABLE 7. VENDOR LANDSCAPE

TABLE 8. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

FIGURE LIST 

FIGURE 1. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2018 & 2027 (IN %)

FIGURE 2. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)

FIGURE 3. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY TRADITIONAL PCR, 2019-2027 (IN $ MILLION)

FIGURE 4. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 (IN $ MILLION)

FIGURE 5. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 6. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY SOFTWARE, 2019-2027 (IN $ MILLION)

FIGURE 7. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY SERVICES, 2019-2027 (IN $ MILLION)

FIGURE 8. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY CLINICAL, 2019-2027 (IN $ MILLION)

FIGURE 9. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY RESEARCH, 2019-2027 (IN $ MILLION)

FIGURE 10. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY FORENSICS, 2019-2027 (IN $ MILLION)

FIGURE 11. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY DIAGNOSTIC CENTERS & HOSPITALS, 2019-2027 (IN $ MILLION)

FIGURE 12. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY BIOTECH & PHARMA COMPANIES, 2019-2027 (IN $ MILLION)

FIGURE 13. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)

FIGURE 14. PORTER’S FIVE FORCE ANALYSIS

FIGURE 15. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 16. CHINA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 17. JAPAN POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 18. INDIA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 19. SOUTH KOREA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20. AUSTRALIA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 21. REST OF ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
  1. MARKET BY TECHNOLOGY
    • REAL-TIME PCR
    • TRADITIONAL PCR
    • DIGITAL PCR
  2. MARKET BY PRODUCT
    • REAGENT AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE
    • SERVICES
  3. MARKET BY APPLICATION
    • CLINICAL
    • RESEARCH
    • FORENSICS
  4. MARKET BY END-USER
    • DIAGNOSTIC CENTERS & HOSPITALS
    • BIOTECH & PHARMA COMPANIES
    • ACADEMIC AND RESEARCH INSTITUTES

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now